Patents by Inventor Maigorzata Donata Gonciarz

Maigorzata Donata Gonciarz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fibroblast growth factor 21 variants having improved pharmacological potency and/or improved pharmaceutical stability
    Patent number: 8541369
    Abstract: This present invention relates to pharmacologically potent and/or stable variants of human fibroblast growth factor 21 (FGF21), pharmaceutical compositions comprising FGF21 variants, and methods for treating type 2 diabetes, obesity, dyslipidemia, or metabolic syndrome, or any combination thereof, using such variants.
    Type: Grant
    Filed: September 25, 2012
    Date of Patent: September 24, 2013
    Assignee: Eli Lilly and Company
    Inventors: Craig Duane Dickinson, David Albert Driver, Ryan James Darling, Maigorzata Donata Gonciarz, Radmila Micanovic